HOME >> BIOLOGY >> NEWS
Center for Science Writings debate: Redesigning Humanity, March 21

HOBOKEN, N.J. The Center for Science Writings at Stevens Institute of Technology presents the debate "Redesigning Humanity: How Far Should We Go?" on Wednesday, March 21, 2007. The event, which will feature a debate between bioethicists Thomas Murray and James Hughes, will be held in the Bissinger Room, located in the Wesley J. Howe Center, from 4:30 p.m. to 6:30 p.m.

"Genetic engineering, stem cells, cloning, pharmaceutical drugs, artificial organs, brain implants and other advances can not only help us overcome disease; they may also allow us to acquire superhuman mental and physical capacities and even to become immortal. This is the hope of so-called transhumanists, who eagerly anticipate a future in which we can transcend our physiological and cognitive limits," said John Horgan, Director of the Center for Science Writings.

"Redesigning Humanity" will feature a debate over the transhumanist vision between two leading bioethicists: Thomas Murray, president of the Hastings Center; and James Hughes, executive director of the World Transhumanist Association and of the Institute for Ethics and Emerging Technologies at Trinity College. This free event is open to the public, and will include light refreshments. For more information, visit www.stevens.edu/csw or contact Horgan at jhorgan@highlands.com.


'"/>

Contact: Stephanie Mannino
smannino@stevens.edu
201-216-5602
Stevens Institute of Technology
12-Mar-2007


Page: 1

Related biology news :

1. Psychiatric Genomics Center established at Cold Spring Harbor Laboratory
2. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
3. Woods Hole Research Center scientists study impacts of industrial logging in Central Africa
4. Innovative smallpox vaccine research study to be conducted at Case Medical Center
5. CSHL selected for odENCODE Data Coordination Center
6. Woods Hole Research Center scientists using remote sensing tools to predict bird species richness
7. NYUs Center for Comparative Functional Genomics part of $57 million MOD-ENCODE consortium
8. Understanding the global carbon budget -- Woods Hole Research Center expert provides insights
9. NIH establishes Center of Excellence for influenza research at Mount Sinai
10. St. Jude named a Center of Excellence in flu research
11. New Geisinger Health System building green Center for Health Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... ... July 21, 2020 , ... ... and innovation in technology and compliance, announces a new solution to manage regulated ... ensure every layer of their technology stack complies with FDA and global regulations. ...
(Date:7/4/2020)... ... 2020 , ... Aesthetics Biomedical (ABM), a leading aesthetics product ... only the products and treatments developed, but also the dedicated team behind the ... brands built by ABM have received several honors already for 2020, each of ...
(Date:6/28/2020)... Switzerland (PRWEB) , ... June ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced that it ... company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
(Date:7/18/2020)... ... 17, 2020 , ... dicentra , a leading Contract ... industries, is pleased to announce that Charles Galea has joined its clinical trials ... is an accomplished and results-driven sales executive with over 10 years of expertise ...
(Date:7/10/2020)... BALTIMORE (PRWEB) , ... July ... ... Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has ... This broader license allows PathSensors to move into the point-of-care diagnostic market, ...
(Date:7/10/2020)... ... 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will ... SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at the ...
Breaking Biology Technology:
Cached News: